FDA Warns of Liver Problems for Some Taking Hep C Drugs

Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the U.S. Food and Drug Administration warned Wednesday.
Source

Please follow and like us:
Facebook
Facebook
TWITTER
Visit Us
INSTAGRAM

Leave a Comment